Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Chao

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
The Oncologist|June 1, 2017
Association of Pre-Chemotherapy Peripheral Blood Pro-Inflammatory and Coagulation Factors with Physical Function in Women with Breast CancerYuan Yuan, Nilesh Vora, Can-Lan Sun, et al.
The Lancet. Oncology|August 14, 2025
Health-related quality of life in patients with KRAS<sup>G12C</sup>-mutated chemorefractory metastatic colorectal cancer treated with sotorasib plus panitumumab or standard of care (CodeBreaK 300): results from a phase 3, randomised clinical trialDominik Paul Modest, Marwan Fakih, Lisa Salvatore, et al.
Journal of the American Geriatrics Society|March 23, 2019
Understanding Caregiver Quality of Life in Caregivers of Hospitalized Older Adults With CancerTina Hsu, Nitya Nathwani, Matthew Loscalzo, et al.
Oncotarget|April 19, 2017
A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinomaPriscila H Goncalves, Lance K Heilbrun, Michael T Barrett, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2019
Phase separation and clustering of an ABC transporter in <i>Mycobacterium tuberculosis</i>Florian Heinkel, Libin Abraham, Mary Ko, et al.
Leukemia Research|June 9, 2012
Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxisRyotaro Nakamura, Joycelynne M Palmer, Margaret R O'Donnell, et al.
Journal for Immunotherapy of Cancer|June 7, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancerRonan J Kelly, Katherine Bever, Joseph Chao, et al.
Cancer Research Communications|February 5, 2025
A Phase 2 Study of Sotigalimab, a CD40 Agonist Antibody, plus Concurrent Chemoradiation as Neoadjuvant Therapy for Esophageal and Gastroesophageal Junction CancersAndrew H Ko, Joseph Chao, Marcus S Noel, et al.
The Oncologist|May 2, 2019
Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for TherapyAparna R Parikh, Yuting He, Ted S Hong, et al.
JCO Precision Oncology|December 8, 2022
Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric CancersBrandon M Huffman, Vasily N Aushev, Griffin L Budde, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
The Oncologist|June 1, 2017
Association of Pre-Chemotherapy Peripheral Blood Pro-Inflammatory and Coagulation Factors with Physical Function in Women with Breast CancerYuan Yuan, Nilesh Vora, Can-Lan Sun, et al.
The Lancet. Oncology|August 14, 2025
Health-related quality of life in patients with KRAS<sup>G12C</sup>-mutated chemorefractory metastatic colorectal cancer treated with sotorasib plus panitumumab or standard of care (CodeBreaK 300): results from a phase 3, randomised clinical trialDominik Paul Modest, Marwan Fakih, Lisa Salvatore, et al.
Journal of the American Geriatrics Society|March 23, 2019
Understanding Caregiver Quality of Life in Caregivers of Hospitalized Older Adults With CancerTina Hsu, Nitya Nathwani, Matthew Loscalzo, et al.
Oncotarget|April 19, 2017
A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinomaPriscila H Goncalves, Lance K Heilbrun, Michael T Barrett, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 2, 2019
Phase separation and clustering of an ABC transporter in <i>Mycobacterium tuberculosis</i>Florian Heinkel, Libin Abraham, Mary Ko, et al.
Leukemia Research|June 9, 2012
Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxisRyotaro Nakamura, Joycelynne M Palmer, Margaret R O'Donnell, et al.
Journal for Immunotherapy of Cancer|June 7, 2023
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of gastrointestinal cancerRonan J Kelly, Katherine Bever, Joseph Chao, et al.
Cancer Research Communications|February 5, 2025
A Phase 2 Study of Sotigalimab, a CD40 Agonist Antibody, plus Concurrent Chemoradiation as Neoadjuvant Therapy for Esophageal and Gastroesophageal Junction CancersAndrew H Ko, Joseph Chao, Marcus S Noel, et al.
The Oncologist|May 2, 2019
Analysis of DNA Damage Response Gene Alterations and Tumor Mutational Burden Across 17,486 Tubular Gastrointestinal Carcinomas: Implications for TherapyAparna R Parikh, Yuting He, Ted S Hong, et al.
JCO Precision Oncology|December 8, 2022
Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric CancersBrandon M Huffman, Vasily N Aushev, Griffin L Budde, et al.
Pageof 12